ArticleFrontiers in immunology2025
Case report: Epidermolysis bullosa acquisita following dipeptidyl peptidase-4 inhibitor therapy and complicated by immune thrombocytopenic purpura.
Hirofumi Kawamoto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.